The functional cardiovascular consequences of vascular calcification

Seminars in Dialysis

Volumn 20, Issue 2, 2007, Pages 122-128

  McIntyre, Christopher W ^a,b,c  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b DERBY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^c DERBY CITY GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUTONOMIC NERVOUS SYSTEM; CALCINOSIS; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY FAILURE; HUMAN; KIDNEY CIRCULATION; MORTALITY; PATHOPHYSIOLOGY; PRESSORECEPTOR REFLEX; UREMIA; VASCULAR RESISTANCE;

AUTONOMIC NERVOUS SYSTEM; BAROREFLEX; CALCINOSIS; CARDIOVASCULAR DISEASES; HUMANS; KIDNEY FAILURE, CHRONIC; RENAL CIRCULATION; UREMIA; VASCULAR RESISTANCE;

EID: 33947314500     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/j.1525-139X.2007.00258.x     Document Type: Article

References (70)

1. London G, Guerin A, Marchais S, Metervier F, Pannier B, Adda H: Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 18:1731-1740, 2003
2. Gipstein R, Coburn J, Adams D, Lee DB, Parsa KB, Sellers A, Suki WN, Massry SG: Calciphylaxis in man. Arch Int Med 136:1273-1280, 1976
3. Goodman W, Goldin J, Kuizon B, Yoon C, Gales B, Sider D, Wang Y, Chung J, Emeriek A, Greaser L, Elashoff RM, Salusky IB: Coronaryartery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 342:1478-1483, 2000
4. Allison MA, Cheung P, Criqui MH, Langer RD, Wright CM: Mitral and aortic annular calcification are highly associated with systemic calcified atherosclerosis. Circulation 113:861-866, 2006
5. Foley R. Parfrey P. Sarnek M: Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 32:S112-S119, 1998
6. Taniwaki H, Ishimura E, Tabata T, Tsujimoto Y, Shioi A, Shoji T, Inaba M, Inoue T, Nishizawa Y: Aortic calcification in hacmodialysis patients with diabetes mellitus. Nephrol Dial Transplant 20:2472-2478, 2005
7. Moe SM: Uremic vasculopathy. Semin Nephrol 24:413-416, 2004
8. Fox E, Harkins D, Taylor H, McMullan M. Han H, Samdarshi T, Garrison R, Skelton T: Epidemiology of mitral annular calcification and its predictive value for coronary events in African Americans: the Jackson Cohort of the Atherosclerotic Risk in Communities Study. Am Heart J 148:979-984, 2004
9. Fox CS, Larson MG, Vasan RS, Guo CY, Parise H, Levy D, Leip EP, O'donnell CJ, D'Agostino Sr RB, Benjamin EJ: Cross-sectional association of kidney function with valvular and annular calcification: the Framingham heart study. J Am Soc Nephrol 17:521-527, 2006
10. Ritschard T, Blumberg A, Jenzer HR: Mitral annular calcification in dialysis patients. Schweiz Med Wochenschr 117:1363-1367, 1987
11. Ribeiro S, Ramos A, Brandao A, Rebelo JR, Gucrra A, Resina C, Vila-Lobos A, Carvalho F, Remedio F, Ribeiro F: Cardiac valve calcification in haemodialysis patients: role of calcium-phosphate metabolism. Nephrol Dial Transplant 13:2037-2040, 1998
12. Wang AY, Wang M, Woo J, Lam CW, Li PK, Lui SF, Sanderson JE: Cardiac valve calcification as an important predictor for all-cause mortality and cardiovascular mortality in long-term peritoneal dialysis patients: a prospective study. J Am Soc Nephrol 14:159-168, 2003
13. Varma R, Aronow WS, McClung JA, Garrick R, Vistainer PF, Weiss MB, Belkin RN: Prevalence of valve calcium and association of valve calcium with coronary artery disease, atherosclerotic vascular disease, and all-cause mortality in 137 patients undergoing hemodialysis for chronic renal failure. Am J Curdiol 95:742-743, 2005
14. Mullens W, Keyser JD, Droogne W: Images in cardiology. Myocardial calcification: a rare cause of diastolic dysfunction. Heart 92:195, 2006
15. Block GA, Spiegel DM, Ehrlich J, Mehta R, Lindbergh J, Dreisbach A, Raggi P: Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis. Kidney Int 68:1815-1824, 2005
16. Dikow R, Kihm LP, Zeier M, Kapitza J, Tornig J, Amann K, Tiefenbacher C, Ritz E: Increased infarct size in uremic rats: reduced ischemia tolerance? J Am Sac. Nephrol 15:1530-1536, 2004
17. Amann K, Tornig J, Kugel B, Gross ML, Tyralla K, El-Shakmak A, Szabo A, Ritz E: Hyperphosphatemia aggravates cardiac fibrosis andmicrovascular disease in experimental uremia. Kidney Int 63:1296-1301, 2003
18. Janigan DT, Hirsch DJ, Klassen GA, MacDonald AS: Calcified subcutaneous arlerioles with infarets of the subculis and skin ("calciphylaxis") in chronic renal failure. Am J Kidney Dis 35:588-597, 2000
19. Alpert MA: Cardiac performance and morphology in end-stage renal disease. Am J Med Sci 325:168-178, 2003
20. Isotalo PA, Halil A, Green M, Tang A, Lach B, Veinot JP: Metastatic calcification of the cardiac conduction system with heart block: an under-reported entity in chronic renal failure patients. J Forensic Sci 45:1335-1338, 2000
21. Aronow WS, Schwanz KS, Koenigsberg M: Correlation of atrial fibrillation with presence or absence of mitral anular calcium in 604 persons older than 60 years. Am J Cardiol 59:1213-1214, 1987
22. Das M, Aronow WS, McClung JA, Belkin RN: Increased prevalence of coronary artery disease, silent myoeardial ischemia, complex ventricular arrhythmias, atrial fibrillation, left ventricular hypertrophy, mitral annular calcium, and aortic valve calcium in patients with chronic renal insufficiency. Cordial Rev 14:14-17, 2006
23. Wei K, Kaul S: The coronary microcirculation in health and disease. Curdiol Clin 22:221-231, 2004
24. Chilian WM, Toyota E, Koshida R, Hattan N, Chilsian WM: Regulation of coronary vasomolor tone: What we know and where we need to go. J Nucl Cordiol 8:599-605, 2001
25. Olivotto I, Cecchi F, Camici PG: Coronary microvascular dysfunction and ischemia in hypertrophie cardiomyopathy. Mechanisms and clinical consequences. ltal Heart J 5:572-580, 2004
26. Selby NM, Lambie SH, Camici PG, Baker CS, MeIntyre CW: Occurrence of regional left ventricular dysfunction in patients vindergoing standard and biofeedback dialysis. Am J Kidney Dis 47:830-841, 2006
27. Ragosta M, Samady H, Isaacs RB, Gimpie LW, Saremboek IJ, Powers ER: Coronary flow reserve abnormalities in patients with diabetes mellitus who have end-stage renal disease and normal epicardial coronary arteries. Am Heart J 147:1017-1023, 2004
28. Gibbons GH, Dzau VJ: The emerging concept of vascular remodeling. N Engl J Med 330:1431 -1438, 1994
29. Mulvany MJ: The fourth Sir George Pickering memorial lecture. The structure of the resistance vasculature in essential hypertension. J Hypertens 5:129-136, 1987
30. Zarins CK, Zatina MA, Giddens DP, Ku DN, Glagov S: Shear stress regulation of artery lumen diameter in experimental alherogenesis. J Vase Surg 5:413-420, 1987
31. Davies PF: Flow-mediated endothelial mechanotransduction. Physiol Rev 75:519-560, 1995
32. Ketteler M, Gross M-L, Ritz E: Calcification and cardiovascular probelems in renal failure. Kidney Int 67:S120-8127, 2005
33. London GM, Guerin A: Influence of arterial pulse and reflective waves on systolic blood pressure and cardiac function. J Hypertens Suppl 17:S3-86, 1999
34. London GM: Large arteries haemodynamics: conduit versus cushioning function. Blood Press 2(Suppl.):48-51, 1997
35. Ferro CJ, Savage T, Finder SJ, Tomson CR: Central aortic pressure augmentation in stable renal transplant recipients. Kidney Int 62:166-171, 2002
36. Savage MT, Ferro CJ, Pinder SJ, Tomson CR: Reproducibility of derived central arterial waveforms in patients with chronic renal failure. Clin Sci (Land) 103:59-65, 2002
37. O'Rourke M PA, Kon N: Generation of ascending aortic from radial artery waveform. J Am Coll Cordial 39(Suppl. B.):177B, 2002
38. Blacher J, Pannier B, Guerin AP, Marchais SJ, Safar ME, London GM: Carotid arterial stiffness as a predictor of cardiovascular and all-cause mortality in end-stage renal disease. Hypertension 32:570-574, 1998
39. Blacher J, Guerin AP, Pannier B, Marchais SJ, London GM: Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 38:938-942, 2001
40. Sigrist M, Bungay P, Taal MW, McIntyre CW: Vascular calcification and cardiovascular function in chronic kidney disease. Nephrol Dial Transplant 21:707-714, 2006
41. Kullo IJ, Bielak LF, Turner ST, Sheedy PF II, Peyser PA: Aortic pulse wave velocity is associated with the presence and quantity of coronary artery calcium: a community-based study. Hypertension 47:174-179, 2006
42. Blacher J. Guerin AP, Pannier B, Marchais SJ. Safar ME. London GM: Impact of aortic stiffness on survival in end-stage renal disease. Circulation 99:2434-2439, 1999
43. Sigrist MK, McIntyre CW: Vascular calcification is associated with impaired microcirculatory function in chronic haemodialysis patients. Poster presentation. British Renal Association, 2006
44. Stenvinkel P. Pecotis-Filho R, Lindholm B: Coronary artery disease in end-stage renal disease: no longer a simple plumbing problem. J Am Soc Nephrol 14:1927-1939, 2003
45. Buckberg GD, Fixler DE, Archie JP, Hoffman JI: Experimental subendocardial ischemia in dogs with normal coronary arteries. Circ Res 30:67-81, 1972
46. Fang ZY, Prins JB, Marwick TH: Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. Endocr Rev 25:543-567, 2004
47. Tok D, Gullu H, Erdogan D, Topcu S, Ciftci O, Yildirim I, Muderrisoglu H: Impaired coronary flow reserve in hemodialysis patients: a transthoracic Doppler echocardiographic study. Nephron Clin Pract 101:200-206, 2005
48. Ohtsuka S, Kakihana M, Watanabe H, Sugishita Y: Chronically decreased aortic distensibility causes deterioration of coronary perfusion during increased left ventricular contraction. J Am Coll Cardiol 24:1406-1414, 1994
49. Kass DA: Ventricular arterial stiffening: integrating the pathophysiology. Hypertension 46:185-193, 2005
50. Maule S, Veglio M, Mecca F, Matteoda C, Chiandussi L: Autonomic neuropathy and QT interval in hemodialysed patients. Clin Auton Res 14:233, 2004
51. Lerma C, Minzoni A, Infante O, Jose MV: A mathematical analysis for the cardiovascular control adaptations in chronic renal failure. Artif Organs 28:398, 2004
52. Coquet I, Mousson C, Rifle G, Laurent G, Moreau D, Cotlin Y, Zoller M, Touzery C, Wolf JE: Influence of ischemia on heart-rate variability in chronic hemodialysis patients. Ren Full 27:7, 2005
53. Rubinger D, Revis N, Pollak A, Luria MH, Sapoznikov D: Predictors of haemodynamic instability and heart rate variability during haemodialysis. Nephrol Dial Transplant 19:2053, 2004
54. Robinson TG, Carr SJ: Cardiovascular autonomic dysfunction in uremia. Kidney Int 62:1921-1932, 2002
55. Smyth HS, Sleight P, Pickering GW: Reflex regulation of arterial pressure during sleep in man. A quantitative method of assessing baroreflex sensitivity. Circ Res 24:109-121, 1969
56. Chesterton LJ, Sigrist MK, Bennett T, MdIntyre CW: Reduced baroreflex sensitivity is associated with increased vascular calcification and arterial stiffness. Ncphrol Dial Transplant 20:1140-1147, 2005
57. Kotanko P: Cause and consequences of sympathetic hyperactivity in chronic kidney disease. Blood Purif 74:95-99, 2006
58. Chesterton LJ, Sigrist MK, McIntyre CW: Reduced BRS is associated with arterial calcification in CKD 4 patients. Poster presentation. British Renal Association, 2006
59. Chapleau MW. Hajduezok G, Abboud FM: Peripheral and central mechanisms of baroreflex reselling. Clin Exp Phamiacol Physiol 15(Suppl.):1-43, 1989
60. Covic A, Goldsmith DJ, Florea L, Gusbeth-Tatomir P, Covic M: The influence of dialytic modality on arterial stiffness, pulse wave reflections, and vasomotor function. Perit Dial Int 24:365, 2004
61. Chertow CM, Burke SK, Raggi P: Treat to goal working group. Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int 62:245-252, 2002
62. Fuessl HS, Schalzky H, Schewe S, Frey KW, Goebel FD: Pathogenesis and clinical significance of Monckeberg medial calcinosis. Klin Wochenschr 63:211-216, 1985
63. Goebel FD, Fuessl HS: Monckeberg's sclerosis after sympathetic denervation in diabetic and non-diabetic subjects. Diabetologia 24:347-350, 1983
64. Takeda S: Central control of bone remodeling. Biochem Biophys Res Commun 328:697-699, 2005
65. Togari A: Adrenergic regulation of bone metabolism: possible involvement of sympathetic innervation of osleoblaslic and osleoclastic cells. Microsc Res Tech 58:77-84, 2002
66. Taylor JE, Belch JJ, Henderson IS, Stewart WK: Peripheral microcirculatory blood flow in haemodialysis patients treated with erythropoietin. Int Anglol 15:33-38, 1996
67. Farkas K, Nemcsik J, Kolossvary E, Jarai Z, Nadory E, Farsang C, Kiss I: Impairment of skin microvascular reactivity in hypertension and uraemia. Nephrol Dial Transplant 20:1821-1827, 2005
68. Ichimaru K. Horie A: Microangiopathic changes of subepidermal capillaries in end-stage renal failure. Nuphron 46:144-149, 1987
69. Savazzi GM, Cusmano F, Musini S: Cerebral imaging changes in patients with chronic renal failure treated conservatively or in hemodialysis. Nephron 89:31-36, 2001
70. Savazzi GM, Cusmano F, Degasperi T: Cerebral atrophy in patients on long-term regular hemodialysis treatment, Clin Nephrol 23:89-95, 1985